Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cellular Immunology|September 10, 2011
Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1Dan Zhao, Shereen Amria, Azim Hossain, et al.Cells|August 13, 2025
B-Cell Lymphomas Secrete Novel Inhibitory Molecules That Disrupt HLA Class II-Mediated CD4+ T-Cell RecognitionJason M God, Shereen Amria, Christine A Cameron, et al.Immunology|March 18, 2014
Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognitionJason M God, Dan Zhao, Christine A Cameron, et al.Cancer Immunology, Immunotherapy : CII|March 18, 2008
Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanomaOliver G Goldstein, Laela M Hajiaghamohseni, Shereen Amria, et al.European Journal of Immunology|May 29, 2008
HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognitionShereen Amria, Laela M Hajiaghamohseni, Caroline Harbeson, et al.International Journal of Molecular Sciences|December 11, 2022
Peptide Modification Diminishes HLA Class II-restricted CD4+ T Cell Recognition of Prostate Cancer CellsBently P Doonan, Shereen Amria, Jennifer R Bethard, et al.Clinical & Developmental Immunology|December 14, 2011
HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognitionAzim Hossain, Jason M God, Faisal F Y Radwan, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumorsJason M God, Christine Cameron, Janette Figueroa, et al.Pageof 1